Cover Image
市場調查報告書

肝膽疾病:全球臨床實驗檢討

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 239409
出版日期 內容資訊 英文 51 Pages
訂單完成後即時交付
價格
Back to Top
肝膽疾病:全球臨床實驗檢討 Hepatobiliary Disease Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月27日 內容資訊: 英文 51 Pages
簡介

本報告提供肝膽疾病相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7·E7各國的臨床實驗狀況,各地區、Phase、階段別進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,並彙整有潛力的藥劑比較等資訊。

簡介

  • 肝膽疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量; 亞太地區
    • 主要國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美

G7各國的臨床實驗數量: 肝膽疾病臨床實驗數量上消化管疾病臨床實驗數量所佔的比例

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:肝膽疾病臨床實驗數量上消化管疾病臨床實驗數量所佔的比例

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Pfizer Inc.
  • 有代表性的研究機關/醫院臨床實驗概要
    • 廣島大學醫院
    • 北海道大學醫院
    • 大阪大學
    • 東京大學
    • 千葉大學
    • Guangdong Science and Technology Department
    • Haydarpasa Numune State Hospital
    • 北海道大學醫學系
    • Japanese Endoscopist & IVRists group for Biliary Tract Cancer
    • 京都府立醫科大學

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2643CTIDB

GlobalData's clinical trial report, "Hepatobiliary Disease Global Clinical Trials Review, H1, 2015" provides data on the Hepatobiliary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatobiliary Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatobiliary Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hepatobiliary Disease
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Hepatobiliary Disease
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Hiroshima University Hospital
      • Clinical Trial Overview of Hiroshima University Hospital
      • Hokkaido University Hospital
      • Clinical Trial Overview of Hokkaido University Hospital
      • Osaka University
      • Clinical Trial Overview of Osaka University
      • The University of Tokyo
      • Clinical Trial Overview of The University of Tokyo
      • Chiba University
      • Clinical Trial Overview of Chiba University
      • Guangdong Science and Technology Department
      • Clinical Trial Overview of Guangdong Science and Technology Department
      • Haydarpasa Numune State Hospital
      • Clinical Trial Overview of Haydarpasa Numune State Hospital
      • Hokkaido University School of Medicine
      • Clinical Trial Overview of Hokkaido University School of Medicine
      • Japanese Endoscopist & IVRists group for Biliary Tract Cancer
      • Clinical Trial Overview of Japanese Endoscopist & IVRists group for Biliary Tract Cancer
      • Kyoto Prefectural University of Medicine
      • Clinical Trial Overview of Kyoto Prefectural University of Medicine
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hepatobiliary Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Hepatobiliary Disease Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University Hospital, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Science and Technology Department, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Haydarpasa Numune State Hospital, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Endoscopist & IVRists group for Biliary Tract Cancer, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015*

List of Figures

  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top